VIDEO from Medialink and Abiomed: World's Smallest Heart Pump Receives 510(K) Clearance from FDA

NEW YORK, June 3 The U.S. Food and Drug Administration(FDA) just cleared the Impella 2.5 Cardiac Assist Device for immediate use.Designed for cardiac arrest and heart attack patients, it pumps up to 2.5liters of blood per minute, and supports the heart in situations when itcannot function on its own. Each year over a million people in the U.S. havea heart attack, according to the National Institutes of Health. Of thatstatistic, half of them die and many are left with permanent heart damage.

As the world's smallest Ventricular Assist Device (VAD), this technologyprovides patients with immediate, sustained coronary perfusion when theirheart is unable to do so. The Impella 2.5 is inserted percutaneously in thecatheterization laboratory (cath lab) through the femoral artery into the leftventricle. It is the only device designed to actively unload blood from theventricle and is approved for short term use for up to six hours.

The clearance allows Abiomed to begin selling the device for use to theestimated 14,000 interventional cardiologists at approximately 1,700 hearthospitals in the United States.

For more information, go to http://www.abiomed.com.

Registered journalists can access video, audio, text, graphics and photosfor free and unrestricted use at http://www.mediaseed.tv.

06NY08-0084(See video from Abiomed, Inc. at:http://media.medialink.com/WebNR.aspx?story=35182)

SOURCE Medialink and Abiomed

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...